Unlicensed drugs worth Rs 1.20 crore seized in Patna

PATNA: Acting on a tip-off, the directorate of drugs control on Friday seized unlicensed medicines worth Rs1.20 crore from a shop-cum-godown in Narayan market on Govind Mitra Road, the hub of drug trade, in the state capital.

A seven-member team, led by Dr Sachchidanand Vikrant, assistant director, directorate of drugs control administration, raided the shop and seized drugs of various brands illegally stored for sale.
“It is illegal to trade such medicines without obtaining license from the government. All such medicines, including some common ones like paracetamol and cough syrups, were seized instantly,” said Vikrant. The details of seizure would be produced before a court for further legal action, he said.

Govind Mitra Road houses over 3,000 retail and wholesale shops and godowns of medicines, which are supplies all over the state.

Related Posts

LB Pharma Begins Pivotal Phase 3 Schizophrenia Trial

Phase 2 results for LB-102 showed statistically significant reductions in PANSS total score across all doses with onset by week 1 and sustained through study end, alongside low rates of…

Check manufacturing, sale of 26 unapproved drugs, central regulator tells state authority

After substandard drug manufacturing, the state drug firms are once again under the scanner of the central government for manufacture and sale of unapproved fixed dose combination (FDC) drugs which…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

LB Pharma Begins Pivotal Phase 3 Schizophrenia Trial

LB Pharma Begins Pivotal Phase 3 Schizophrenia Trial

Check manufacturing, sale of 26 unapproved drugs, central regulator tells state authority

Check manufacturing, sale of 26 unapproved drugs, central regulator tells state authority

Stem cell therapy for autism illegal: NMC advisory

Stem cell therapy for autism illegal: NMC advisory

India’s Essential Medicines Prices To Increase Marginally From 1 April Under Annual Pricing Framework

India’s Essential Medicines Prices To Increase Marginally From 1 April Under Annual Pricing Framework

Delhi HC Asks Dr Reddy’s To Halt Olymviq Sales; Flags Similarity With Novo Nordisk’s Ozempic

Delhi HC Asks Dr Reddy’s To Halt Olymviq Sales; Flags Similarity With Novo Nordisk’s Ozempic

NPPA allows 0.64% hike in MRP of essential drugs in line with WPI rise

NPPA allows 0.64% hike in MRP of essential drugs in line with WPI rise